David Young

Fondateur chez PROCESSA PHARMACEUTICALS, INC. Fortune : 44 934 $ au 30/06/2026

Profil

David Young was the founder of GloboMax LLC, founded in 2003, serving as Chief Executive Officer.
Dr. Young is the founder of Processa Pharmaceuticals, Inc., founded in 2011, serving as Director, President-Research & Development.
Dr. Young was the founder of Promet Therapeutics LLC, founded in 2015, serving as Chief Executive & Financial Officer.
Former jobs include Director, Chief Executive & Financial Officer at Heatwurx, Inc.; Managing Director-Clinical Research Unit at the University of Maryland; President & Executive Director at AGI Therapeutics, Inc. from 2006 to 2009; President & Executive Director at AGI Therapeutics Plc from 2006 to 2009; Chief Scientific Officer at Questcor Pharmaceuticals, Inc. from 2009 to 2014; EVP-Strategic Drug Development Division at ICON plc from 2003 to 2006; Associate Professor at the University of Maryland School of Pharmacy from 1986 to 1997.
Education includes a doctorate from the University of Southern California, graduate studies at the University of Wisconsin, and undergraduate studies at the University of California, Berkeley.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
PROCESSA PHARMACEUTICALS, INC. 0,85 %	30/06/2026	23 403 ( 0,85 % )	44 934 $	30/06/2026

Postes actifs de David Young

Sociétés	Poste	Début
PROCESSA PHARMACEUTICALS, INC.	Fondateur	29/03/2011

Anciens postes connus de David Young

Sociétés	Poste	Fin
QUESTCOR PHARMACEUTICALS INC	Directeur Technique/Scientifique/R&D	01/01/2014
AGI Therapeutics Plc	President	01/10/2009
AGI Therapeutics, Inc.	President	-
ICON PUBLIC LIMITED COMPANY	Corporate Officer/Principal	-
GloboMax LLC	Directeur Général	-